PrecisionLife

Chronic diseases cause suffering for billions of people and cost trillions of dollars to treat every year. The challenge for biopharma and healthcare is to understand which targets and drugs will work with which subgroups of patients. We are a pioneering techbio company, generating the deepest insights into chronic disease biology to unlock patient-focused precision drug discovery, clinical development, and healthcare. Improving health, for everyone. We identify, target, and help treat the biological mechanisms that are driving disease within subgroups of patients, generating stratification biomarkers to improve and derisk pharmaceutical innovation and enable personalized healthcare. Our unique approach finds more signal in patient data than any other method. Our high-resolution patient stratification identifies subgroups of patients with similar disease drivers and treatment responses, to make precision medicine possible in chronic diseases. Our insights discover new drug targets, accelerate and derisk clinical development, find drug repositioning opportunities, and lead to better diagnosis and the prescription of more effective therapies.